Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease.
Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario M, Feagan BG, Bojic D, Trang-Poisson C, Shen B, Altwegg R, Sands BE, Colombel JF, Carbonnel F; GETAID OBSERV-IBD, VICTORY Cohorts Collaboration*. Dulai PS, et al. Among authors: filippi j. Aliment Pharmacol Ther. 2020 Mar;51(5):553-564. doi: 10.1111/apt.15609. Epub 2019 Dec 22. Aliment Pharmacol Ther. 2020. PMID: 31867766 Free PMC article.
Muscle performance in patients with Crohn's disease in clinical remission.
Wiroth JB, Filippi J, Schneider SM, Al-Jaouni R, Horvais N, Gavarry O, Bermon S, Hébuterne X. Wiroth JB, et al. Among authors: filippi j. Inflamm Bowel Dis. 2005 Mar;11(3):296-303. doi: 10.1097/01.mib.0000160810.76729.9c. Inflamm Bowel Dis. 2005. PMID: 15735436
[Treatment of oesophageal Crohn's disease by infliximab].
Filippi J, Mambrini P, Arab K, Schneider SM, Hébuterne X. Filippi J, et al. Gastroenterol Clin Biol. 2005 Jan;29(1):84-5. doi: 10.1016/s0399-8320(05)80701-8. Gastroenterol Clin Biol. 2005. PMID: 15738903 Free article. French. No abstract available.
Incidence of inflammatory bowel disease in Corsica from 2002 to 2003.
Abakar-Mahamat A, Filippi J, Pradier C, Dozol A, Hébuterne X. Abakar-Mahamat A, et al. Among authors: filippi j. Gastroenterol Clin Biol. 2007 Dec;31(12):1098-103. doi: 10.1016/s0399-8320(07)78343-4. Gastroenterol Clin Biol. 2007. PMID: 18176365 Free article.
A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization.
Oussalah A, Evesque L, Laharie D, Roblin X, Boschetti G, Nancey S, Filippi J, Flourié B, Hebuterne X, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Among authors: filippi j. Am J Gastroenterol. 2010 Dec;105(12):2617-25. doi: 10.1038/ajg.2010.345. Epub 2010 Aug 24. Am J Gastroenterol. 2010. PMID: 20736936
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Laharie D, et al. Among authors: filippi j. Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10. Lancet. 2012. PMID: 23063316 Clinical Trial.
235 results